205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.98%
Negative revenue growth while NXPI stands at 3.21%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-10.41%
Negative gross profit growth while NXPI is at 0.13%. Joel Greenblatt would examine cost competitiveness or demand decline.
-26.33%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-26.33%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-12.97%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-12.12%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-12.50%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.35%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
22.65%
Dividend growth above 1.5x NXPI's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
38.54%
Similar OCF growth to NXPI's 37.88%. Walter Schloss would assume comparable operations or industry factors.
78.76%
FCF growth 75-90% of NXPI's 94.26%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
-2.53%
Negative 10Y revenue/share CAGR while NXPI stands at 79.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
16.81%
5Y revenue/share CAGR under 50% of NXPI's 77.31%. Michael Burry would suspect a significant competitive gap or product weakness.
63.75%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
160.39%
10Y OCF/share CAGR above 1.5x NXPI's 104.58%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
34.06%
Below 50% of NXPI's 107.18%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
55.27%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
124.14%
Net income/share CAGR above 1.5x NXPI's 36.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
7.41%
Below 50% of NXPI's 328.95%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
492.03%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
269.66%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
41.08%
5Y equity/share CAGR above 1.5x NXPI's 18.89%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
2.06%
Below 50% of NXPI's 42.98%. Michael Burry suspects a serious short-term disadvantage in building book value.
64.52%
Dividend/share CAGR of 64.52% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
29.35%
Below 50% of NXPI's 169.49%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
13.43%
3Y dividend/share CAGR at 50-75% of NXPI's 20.43%. Martin Whitman might see a weaker short-term approach to distributing cash.
-13.69%
Firm’s AR is declining while NXPI shows 1.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-7.37%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.00%
Asset growth above 1.5x NXPI's 0.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.65%
50-75% of NXPI's 3.20%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-1.04%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
1.04%
R&D dropping or stable vs. NXPI's 4.75%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
3.72%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.